These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 3053183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C, Bohn DJ, Freedom RM, Rabinovitch M.
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [Abstract] [Full Text] [Related]

  • 4. Vasodilator therapy for primary pulmonary hypertension.
    McGoon MD, Vlietstra RE.
    Mayo Clin Proc; 1984 Oct; 59(10):672-7. PubMed ID: 6148467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L, Gavazzi A, Mussini A, Graziano G, Campana C, Bargiggia G, Angoli L, Aimè E, Arbustini E, Montemartini C.
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [Abstract] [Full Text] [Related]

  • 7. Role of pharmacologic tests in the treatment of primary pulmonary hypertension.
    Galiè N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B.
    Am J Cardiol; 1995 Jan 19; 75(3):55A-62A. PubMed ID: 7840056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL, Michelakis ED.
    Curr Opin Cardiol; 2006 Jul 19; 21(4):385-92. PubMed ID: 16755209
    [Abstract] [Full Text] [Related]

  • 10. Calcium blockage in pulmonary hypertension and hypoxic vasoconstriction.
    Neely CF, Stein R, Matot I, Batra V, Cheung A.
    New Horiz; 1996 Feb 19; 4(1):99-106. PubMed ID: 8689279
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.
    Weir EK, Rubin LJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Elliott CG, Fishman AP, Goldring RM, Groves BM.
    Am Rev Respir Dis; 1989 Dec 19; 140(6):1623-30. PubMed ID: 2690706
    [Abstract] [Full Text] [Related]

  • 13. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F.
    Lancet; 2002 Sep 21; 360(9337):895-900. PubMed ID: 12354470
    [Abstract] [Full Text] [Related]

  • 14. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C, Brenot F, Blétry O, Simmonneau G, Duroux P.
    Rev Mal Respir; 1990 Sep 21; 7(3):249-54. PubMed ID: 2114030
    [Abstract] [Full Text] [Related]

  • 15. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W.
    Am J Respir Crit Care Med; 1999 Aug 21; 160(2):600-7. PubMed ID: 10430735
    [Abstract] [Full Text] [Related]

  • 16. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N, McAlpine L, Peacock AJ, Madhok R.
    Arthritis Rheum; 1998 Mar 21; 41(3):466-9. PubMed ID: 9506575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure.
    Sniderman AD, Fitchett DH.
    Int J Cardiol; 1988 Aug 21; 20(2):173-81. PubMed ID: 3061937
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Pneumologie; 2000 Mar 21; 54(3):133-42. PubMed ID: 10783653
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.